Degenerative Disc Disease Clinical Trial
Official title:
A Prospective, Multi-Center, Nonrandomized Study to Assess Lumbar Fusion Using Interbody Cages With Autograft in Conjunction With Instrumented Posterolateral Gutter Fusions Using NanOss Bioactive
Spine fusion is one of the most common procedures performed in spinal surgery. Several
surgical techniques can achieve a solid union, but the intertransverse posterolateral fusion
(PLF) is the most widely used. However, complications can develop when the bone graft
material used is insufficient to achieve the desired fusion. With its unique properties,
nanOss Bioactive can be mixed with bone marrow aspirate (BMA) and other graft materials to
obtain new bone growth during the healing process.
It is hypothesized that the use of nanOss Bioactive will result in fusion at 12 months, with
CT evidence of bridging trabecular bone, less than 3mm of translational motion, and less than
5 degrees of angular motion. In addition, patients are expected to see an improvement in
Oswestry Disability Index scores, VAS pain scores, and SF36 scores, while decreasing the use
of pain medication, returning to work, and finding satisfaction in the results of their
surgery.
The post marketing clinical trial is designed to assess lumbar fusion using interbody cages
with autograft in conjunction with instrumented posterolateral gutter fusions using nanOss
Bioactive bone void filler in patients with degenerative disc disease (DDD) characterized by
the inclusion and exclusion criteria listed below.
Patients for this study will be recruited from up to 10 clinical sites. It is estimated that
100 patients will be enrolled in the study. At least 10 investigators will participate in the
study. Patients who meet the inclusion and exclusion criteria will be asked to sign the
informed consent. Preoperatively, the patient will provide his /her medical history and
complete self assessment forms. The investigator will perform a clinical evaluation.
Patients who meet the criteria for entrance into the study will undergo lumbar fusion using
interbody cages with autograft in conjunction with instrumented posterolateral gutter fusions
using nanOss Bioactive in combination with local autograft and bone marrow aspirate (BMA).
Anterior lumbar interbody fusion procedures are not allowed.
Following surgery, operative and discharge information will be collected. The patients will
be evaluated at 6 weeks, 6 months and 12 months postoperatively. At each postoperative visit,
the investigator will clinically evaluate the patient and the patient will complete self
assessment documents, Oswestry Disability Index, Quality of Life questionnaires and a surgery
satisfaction survey, e.g., very satisfied, satisfied, somewhat unsatisfied, or very
unsatisfied with the surgery. Fusion status will be evaluated radiographically at each visit
using plain films. CT scans at 12 months will be evaluated by an independent radiologist.
Complication data will be recorded throughout the study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04848376 -
Post-Market Clinical Follow-up Study of A-SPINE's Products
|
||
Active, not recruiting |
NCT05114135 -
TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study)
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Withdrawn |
NCT03223701 -
Efficacy of Using Solum IV and BMC With GFC in TLIF
|
Phase 4 | |
Completed |
NCT04057235 -
Retrospective Review of Integrity Implants FlareHawk® for Lumbar Fusion
|
||
Not yet recruiting |
NCT06000319 -
Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
|
||
Active, not recruiting |
NCT02969616 -
Trinity Elite in Lumbar Fusion
|
||
Completed |
NCT02558621 -
New Robotic Assistance System for Spinal Fusion Surgery
|
N/A | |
Completed |
NCT02104167 -
Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating
|
||
Completed |
NCT00965380 -
Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)
|
||
Completed |
NCT00996073 -
Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion
|
Phase 2 | |
Terminated |
NCT00974623 -
Bone Graft Materials Observational Registry
|
N/A | |
Completed |
NCT00758719 -
Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
|
||
Completed |
NCT00165893 -
Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease
|
Phase 4 | |
Terminated |
NCT01494493 -
Pivotal Study of rhBMP-2/ACS/Allograft Bone Dowel for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease
|
N/A | |
Recruiting |
NCT04727385 -
Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease
|
N/A | |
Completed |
NCT04849429 -
Intra-discal Injection of Platelet-rich Plasma (PRP) Enriched With Exosomes in Chronic Low Back Pain
|
Phase 1 | |
Recruiting |
NCT04469387 -
Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion
|
N/A | |
Recruiting |
NCT04056520 -
Clinical and Radiological Outcomes of Posterior Cervical Fusion With Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System
|
||
Completed |
NCT04119466 -
Stabilizing Training in Degenerative Disc Disease
|
N/A |